small molecule

AIRSUPRA

ALBUTEROL SULFATE; BUDESONIDE

Loss of exclusivityMay 2030latest FDA-listed patent expiry

CompanyASTRAZENECA PHARMACEUTICALS LP

Drug detail

Brand name	AIRSUPRA
Active ingredient	ALBUTEROL SULFATE; BUDESONIDE
Strength	EQ 0.09MG BASE/INH;0.08MG/INH
Dosage form	AEROSOL, METERED
Route	INHALATION
Modality	Small molecule
FDA approval	January 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
9415009	May 2030	use U-3509

Regulatory exclusivity

Code	Expires
M-317	September 2028
NP	January 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from ASTRAZENECA PHARMACEUTICALS LP